Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quianyan Alloy Materials (QAM) is a specialty chemical and bioproduct manufacturer based in China that specializes in the production of bio-based specialty products using fermentation and process development expertise. The company is best known for its strategic partnership with the U.S. biotechnology firm zuChem to produce and market bio-sourced xylitol and L-fucose. Through their joint venture, Sweet Appeal Natural Products (formerly NaturSweet), QAM operates a state-of-the-art greenfield manufacturing facility in China that utilizes zuChem's proprietary fermentation technology. QAM's business model focuses on combining Western quality standards and business practices with the cost-effective manufacturing capabilities of China to serve global markets in food, nutrition, and pharmaceuticals. The company's facility in Harbin is the world's first to produce xylitol via a bioprocess rather than traditional chemical hydrogenation. QAM continues to expand its portfolio of rare sugars and pharmaceutical intermediates to support the life sciences and nutrition industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quianyan Alloy Materials.